Andrew King

Andrew King is a Clinical Professor in the Division of Neuroscience at the University of Manchester, specializing in neurosurgical oncology with particular focus on vestibular schwannoma and neurofibromatosis type II. His research examines tumor growth mechanisms, surgical outcomes, and neuroinflammatory responses in brain disorders.

Research interests center on:

• Immunological networks in schwannomatosis
• Microdialysis monitoring of inflammatory biomarkers
• Genetic determinants of tumor development
• Advanced imaging techniques for brain tumor characterization

Publications demonstrate consistent focus on improving neurosurgical techniques for cranial nerve disorders, with recent work exploring macrophage involvement in tumor progression and genetic screening for schwannomatosis. Clinical studies emphasize quantitative outcome measurement and minimally invasive approaches.

Leads multidisciplinary projects including a cohort study on interleukin-1 receptor antagonist effects following subarachnoid hemorrhage. Supervises doctoral candidates investigating tumor immunology and collaborates internationally on neurofibromatosis research.